IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JULIE L ERPS

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1992849236
CMS profile
10807265
Location
HOUSTON, TX

General Payments · PY2021–2024

$3,663.63

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,312.74

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Physician Assistant TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,312.74 55

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $260.51 10
ABBVIE INC. $250.10 13
Lilly USA, LLC $241.94 11
Gilead Sciences, Inc. $186.79 4
Janssen Biotech, Inc. $111.76 5
INTERCEPT PHARMACEUTICALS, INC. $72.07 3
Salix Pharmaceuticals, a division of Bausch Health US, LLC $60.92 4
Celgene Corporation $48.26 2
PFIZER INC. $32.89 1
Phathom Pharmaceuticals, Inc. $32.32 1
EVOKE PHARMA, INC. $15.18 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $433.90 14
PY2022 $977.32 38
PY2023 $939.67 49
PY2024 $1,312.74 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.50 01/12/2024 Food and Beverage Undisputed 01/23/2026 1107077402 CMS
ABBVIE INC. $8.08 02/23/2024 Food and Beverage Undisputed 01/23/2026 1107077404 CMS
ABBVIE INC. $19.02 04/19/2024 Food and Beverage Undisputed 01/23/2026 1107077406 CMS
ABBVIE INC. $22.73 05/16/2024 Food and Beverage Undisputed 01/23/2026 1107077408 CMS
ABBVIE INC. $17.96 06/26/2024 Food and Beverage Undisputed 01/23/2026 1107077410 CMS
ABBVIE INC. $12.00 07/30/2024 Food and Beverage Undisputed 01/23/2026 1107077412 CMS
ABBVIE INC. $16.43 08/05/2024 Food and Beverage Undisputed 01/23/2026 1107077414 CMS
ABBVIE INC. $21.94 08/20/2024 Food and Beverage Undisputed 01/23/2026 1107077416 CMS
ABBVIE INC. $16.05 09/17/2024 Food and Beverage Undisputed 01/23/2026 1107077418 CMS
ABBVIE INC. $14.99 10/10/2024 Food and Beverage Undisputed 01/23/2026 1107077420 CMS
ABBVIE INC. $27.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1107077422 CMS
ABBVIE INC. $24.83 11/15/2024 Food and Beverage Undisputed 01/23/2026 1107077424 CMS
ABBVIE INC. $32.57 12/19/2024 Food and Beverage Undisputed 01/23/2026 1107077426 CMS
Celgene Corporation $15.01 07/26/2024 Food and Beverage Undisputed 01/23/2026 1101112924 CMS
Celgene Corporation $33.25 09/06/2024 Food and Beverage Undisputed 01/23/2026 1101112926 CMS
EVOKE PHARMA, INC. $15.18 10/11/2024 Food and Beverage Undisputed 01/23/2026 1127779007 CMS
Gilead Sciences, Inc. $17.66 08/26/2024 Food and Beverage Undisputed 01/23/2026 1133720871 CMS
Gilead Sciences, Inc. $121.86 10/03/2024 Food and Beverage Undisputed 01/23/2026 1133720873 CMS
Gilead Sciences, Inc. $23.52 10/11/2024 Food and Beverage Undisputed 01/23/2026 1133720875 CMS
Gilead Sciences, Inc. $23.75 10/28/2024 Food and Beverage Undisputed 01/23/2026 1133720877 CMS
Intercept Pharmaceuticals, Inc. $27.23 05/24/2024 Food and Beverage Undisputed 01/23/2026 1113650295 CMS
Intercept Pharmaceuticals, Inc. $24.92 05/31/2024 Food and Beverage Undisputed 01/23/2026 1113650293 CMS
Intercept Pharmaceuticals, Inc. $19.92 08/09/2024 Food and Beverage Undisputed 01/23/2026 1113650297 CMS
Janssen Biotech, Inc. $22.77 03/07/2024 Food and Beverage Undisputed 01/23/2026 1078729787 CMS
Janssen Biotech, Inc. $22.96 04/13/2024 Food and Beverage Undisputed 01/23/2026 1078726806 CMS
Janssen Biotech, Inc. $17.51 05/10/2024 Food and Beverage Undisputed 01/23/2026 1078721856 CMS
Janssen Biotech, Inc. $20.15 08/27/2024 Food and Beverage Undisputed 01/23/2026 1078726879 CMS
Janssen Biotech, Inc. $28.37 10/05/2024 Food and Beverage Undisputed 01/23/2026 1078729624 CMS
Lilly USA, LLC $21.69 01/19/2024 Food and Beverage Undisputed 01/23/2026 1135717762 CMS
Lilly USA, LLC $33.37 06/22/2024 Food and Beverage Undisputed 01/23/2026 1135701814 CMS
Lilly USA, LLC $2.77 07/26/2024 Food and Beverage Undisputed 01/23/2026 1135721021 CMS
Lilly USA, LLC $24.17 07/26/2024 Food and Beverage Undisputed 01/23/2026 1135728845 CMS
Lilly USA, LLC $19.35 08/23/2024 Food and Beverage Undisputed 01/23/2026 1135721023 CMS
Lilly USA, LLC $28.25 09/20/2024 Food and Beverage Undisputed 01/23/2026 1135730968 CMS
Lilly USA, LLC $28.81 10/04/2024 Food and Beverage Undisputed 01/23/2026 1135719816 CMS
Lilly USA, LLC $27.48 10/07/2024 Food and Beverage Undisputed 01/23/2026 1135647479 CMS
Lilly USA, LLC $1.25 11/08/2024 Food and Beverage Undisputed 01/23/2026 1135701816 CMS
Lilly USA, LLC $23.98 11/08/2024 Food and Beverage Undisputed 01/23/2026 1135721025 CMS
Lilly USA, LLC $30.82 11/11/2024 Food and Beverage Undisputed 01/23/2026 1135647481 CMS
PFIZER INC. $32.89 01/31/2024 Food and Beverage Undisputed 01/23/2026 1131558610 CMS
Phathom Pharmaceuticals, Inc. $32.32 03/02/2024 Food and Beverage Undisputed 01/23/2026 1151163704 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.54 01/31/2024 Food and Beverage Undisputed 01/23/2026 1153497496 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.97 02/07/2024 Food and Beverage Undisputed 01/23/2026 1153575346 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.78 08/14/2024 Food and Beverage Undisputed 01/23/2026 1153627403 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.63 12/16/2024 Food and Beverage Undisputed 01/23/2026 1153558151 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.24 01/26/2024 Food and Beverage Undisputed 01/23/2026 1137739930 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.73 02/09/2024 Food and Beverage Undisputed 01/23/2026 1137739932 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.55 03/15/2024 Food and Beverage Undisputed 01/23/2026 1137739934 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.73 06/07/2024 Food and Beverage Undisputed 01/23/2026 1137739936 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.59 08/19/2024 Food and Beverage Undisputed 01/23/2026 1137739938 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.10 08/23/2024 Food and Beverage Undisputed 01/23/2026 1137739940 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.91 09/23/2024 Food and Beverage Undisputed 01/23/2026 1137739942 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.93 09/27/2024 Food and Beverage Undisputed 01/23/2026 1137739944 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.99 11/19/2024 Food and Beverage Undisputed 01/23/2026 1137739946 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.74 12/13/2024 Food and Beverage Undisputed 01/23/2026 1137739948 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.